ArticleTherapeutic advances in medical oncology2022
Improving the tolerability of osimertinib by identifying its toxic limit.
Bram C Agema et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it